Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Testosterone study finds differing disease links in men and women
LONDON (Reuters) - Having genetically higher levels of the sex hormone testosterone increases the risk of developing diabetes and some types of cancer in women, and reduces diabetes risk but r...
Advance team of WHO experts arrives in China to probe coronavirus
GENEVA/LONDON (Reuters) - An advance team of World Health Organization medical experts arrived in China on Monday to help investigate the coronavirus outbreak, WHO chief Tedros Adhanom Ghebrey...
Dupixent sales of €10B? We're on track, Sanofi CEO Hudson says
Under new CEO Paul Hudson, Sanofi has placed a huge emphasis on immunology blockbuster Dupixent with aims to grow sales to €10 billion or more per year.
AstraZeneca expanding again in Australia, pledging $133M investment at Sydney site and adding 250 jobs
AstraZeneca has been pouring money into its Australian manufacturing site as demand for its respiratory meds has grown in China and elsewhere.
Novo Nordisk investing $117.4M in manufacturing site in Denmark
Novo Nordisk’s site in Kalundborg, Denmark, already manufactures about half of the world’s insulin, but with a DKK 800 million makeover the site will be able to produce even more insulin and other...
GSK cutting 720 jobs in manufacturing, R&D and support functions at massive Belgian vaccine hub
GlaxoSmithKline’s vaccines unit has been a bright spot for the company amid challenges elsewhere, but its recent performance doesn’t make it immune to staff cuts.
Zynerba Pharmaceuticals Announces Achievement of Patient Screening Target for Pivotal Trial of Zygel™ in Fragile X Syndrome
DEVON, Pa.
Biogen shares soar 32% on MS drug patent win over Mylan
(Reuters) - Biogen Inc’s shares surged as much as 32% on Wednesday after the drugmaker won a favorable U.
China may delay annual meeting of parliament due to virus outbreak: sources
BEIJING (Reuters) - China is considering delaying the annual meeting of its top legislative body, five people familiar with the matter said, as it grapples with a virus epidemic that has force...
Genentech’s Risdiplam Showed Significant Improvement in Motor Function in People Aged 2-25 With Type 2 or 3 Spinal Muscular Atrophy
SOUTH SAN FRANCISCO, CA, USA I February 06, 2020 I Genentech, a member of the Roche Group (SIX.
FDA grants emergency nationwide use to CDC's coronavirus test
The FDA has granted an emergency authorization to the Centers for Disease Control and Prevention’s (CDC's) novel coronavirus diagnostic, allowing it to be used at qualified and designate...
Lonza keeps Chinese plants on 'holiday' as coronavirus builds momentum
Swiss CDMO Lonza is extending the Chinese New Year break at its four plants in China, but not to celebrate.
326
327
328
329
330
331
332
333
334
